Cargando…
Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
BACKGROUND: Immunosuppressed patients such as kidney transplant recipients (KTs) have increased mortality risk in the setting of coronavirus disease 2019 (COVID-19). The role and management of chronic immunosuppressive therapies during COVID-19 must be characterized. METHODS: Herein, we report the f...
Autores principales: | Anton Pampols, Paula, Trujillo, Hernando, Melilli, Edoardo, Urban, Blanca, Sandino, Justo, Favá, Alexandre, Gutierrez, Eduardo, Bestard, Oriol, Mancebo, Esther, Sevillano, Angel, Cruzado, Josep M, Morales, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929031/ https://www.ncbi.nlm.nih.gov/pubmed/34282376 http://dx.doi.org/10.1093/ckj/sfab025 |
Ejemplares similares
-
Targets of new immunosuppressants in renal transplantation
por: Cruzado, Josep M, et al.
Publicado: (2011) -
Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?
por: Melilli, Edoardo, et al.
Publicado: (2018) -
The Presence of Urinary Renal Progenitor Cells in Stable Kidney Transplant Recipients Anticipates Allograft Deterioration
por: Manonelles, Anna, et al.
Publicado: (2018) -
Pre-Transplant Donor-Specific T-Cell Alloreactivity Is Strongly Associated with Early Acute Cellular Rejection in Kidney Transplant Recipients Not Receiving T-Cell Depleting Induction Therapy
por: Crespo, Elena, et al.
Publicado: (2015) -
Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)